News and Trends 23 Apr 2016
BioArt : Katharine Dowson’s Brain Boxes, Crystal Chromosomes & HIV Vaccine Work
Represented by the GV Art Gallery in London, Katharine Dowson is a glass sculptor who is well established in the BioArt community…
Neurological disorders
- Latest Posts
News and Trends 22 Apr 2016
UK Cannabis Biotech gets another Orphan Drug Designation by the FDA
Cambridge based GW Pharmaceuticals has now been granted Orphan Drug Designation from FDA for Cannabidiol drug to treat a 3rd rare genetic…
News and Trends 18 Apr 2016
ITW: This Biotech Startup wants to fix Youth Blindness with a Gene Therapy
While on a stop in New York, I had a chance to chat with Bernard Gilly, the founder and CEO…
News and Trends 16 Apr 2016
First Euronext Biotech IPO of 2016 is Swiss, and for Multiple Sclerosis!
We last wrote about GeNeuro in January, when they announced the launch of an IPO for their Multiple Sclerosis phase…
ADVERTISEMENT
News and Trends 11 Apr 2016
It’s World Parkinson’s Disease Day! #EndParkinsons
Today (April 11th) is the birthday of the memorable Dr James Parkinson, who discovered this major neurodegenerative disease. So what…
News and Trends 11 Apr 2016
French Biotech gets €34M to bring Multiple Sclerosis Drug to the US
MedDay (France) has raised €34M that should help pay a US phase III for its leading candidate for Multiple Sclerosis - as…
News and Trends 7 Apr 2016
Allergan Signs Massive €3Bn Alzheimer’s Deal with UK Biotech
Heptares Therapeutics is licensing its portfolio of novel candidates for neurological diseases, including one for Alzheimer's, to Allergan for up to…
News and Trends 24 Mar 2016
Leading German Biotech recruits New talent for Fight against Alzheimer’s
Probiodrug (Germany) has hired Mark Booth as Chief Business Officer to propel this Pharma's global strategy. Among other important roles,…
News and Trends 17 Mar 2016
A Relief for Migraines at last? The Biotech race for the Ultimate Cure
A Migraine is more than just a headache; it is a neurological disorder affecting a staggering 10% of the worldwide…
News and Trends 3 Mar 2016
Reviewing Autism: Can Biotech open up New Horizons?
While Autism Spectrum Disorders (ASD) affect approximately one in 68 children, this hasn't provoked much enthusiasm among pharmaceutical companies to…
ADVERTISEMENT
News and Trends 11 Feb 2016
Sanofi-Genzyme: Still successful 5 years after the acquisition?
Back in 2011, France's biggest Pharmaceutical company Sanofi decided to purchase Genzyme Corp. for more than $20 billion, thus becoming…
News and Trends 4 Feb 2016
Finland, France and Harvard Bioprint Brains to Understand the 3D Structure
Researchers at Harvard University in collaboration with French and Finnish academic institutions have managed to 3D-bioprint a brain with the distinctive…
News and Trends 25 Jan 2016
Also Using PD-L1 Cancer Treatments to Attack Alzheimer’s Disease
What updates have occurred in the Neurodegenerative disease field as of late? New appointments by the Dementia Discovery Fund, which…
News and Trends 22 Jan 2016
Groningen’s MedTech Hub for Neurosurgery is Actually a Biotech Hotspot
I visited Groningen (Netherlands) and the University Medical centre there in November, and it was interesting to note the tight knit…
News and Trends 8 Jan 2016
Epigenetics Baby of Proteros is Signing Up with Top US Neurology Specialists
Founded in just 2013 by German Proteros and the US Atlas Ventures, Rodin Therapeutics is working epigenetics into discovery of…
News and Trends 6 Jan 2016
Growing Mini-Brains in Labs to Better Understand Neurological Disease
Mini brains, about 3-4 mm are a breakthrough in Neurology which will enable researchers to study the development of neurological…
ADVERTISEMENT
News and Trends 22 Dec 2015
Dutch Organ-on-Chip Biotech Hauls in €1.5M Funding from Pharma Syndicate in Project Against Animal Testing
Mimetas from Leiden (NL) has now been financed to develop an Organ-on-Chip (tissue model) to specifically test Neurotoxicity, as a…
News and Trends 15 Dec 2015
Latest Small Molecule against Alzheimer’s Disease Success in Phase I Trials
Probiodrug's phase I tolerability and efficacy trial for Alzheimer's didn't quite go as planned, although results are in and it…
News and Trends 7 Dec 2015
Hydra’s Immortality is not Myth: Polyps Genetically Reprogram Skin Cells into Neurons
Relatives of the Jellyfish, researchers at the University of Geneva (Switzerland) have now proven the regenerative abilities of Hydra involved…
News and Trends 4 Dec 2015
Black Friday Ruin as TWO Biotechs Fail in Phase III Trials
A shocking Black Friday for these two Biotechs: Both CytoTools (Germany) and MedDay (France) phase III trials in chronic disease…